• Uremic Metabolite Adsorption on Hydroxy-PEO Films

  2026-08-20

  This 2025 study advances uremic-toxin research by measuring adsorption of a 25-metabolite mixture on hydroxy-terminated polyethylene oxide films rather than relying on single-analyte or protein-only models. Its results show that PEO chain density, incubation time, end-group chemistry, and metabolite structure jointly determine surface retention, providing a more realistic framework for blood-contacting biomaterial design.

• CART–RNA Nanoparticles: Structure and Morphology

  2026-08-19

  Hurst and colleagues define how degradable Charge-Altering Releasable Transporter amphiphiles organize RNA into coacervate nanoparticles with disordered bicontinuous internal domains. By combining cryo-electron microscopy, tomography, and small-angle scattering, the study links amphiphile molar mass, chemical structure, and RNA cargo identity to nanoscale morphology, offering experimentally testable principles for polymer-based RNA delivery design.

• AP2-M Controls Babesia Asexual Replication

  2026-08-19

  A 2024 study identifies AP2-M, an Apicomplexan AP2-family transcription factor, as a regulator of red blood cell invasion, merozoite morphology, and cell-cycle progression in Babesia sp. Xinjiang. By combining Cut&Tag, RNA sequencing, proteomics, and single-cell RNA sequencing, the authors connect promoter occupancy with parasite-stage-specific transcriptional and phenotypic changes.

• PDGF-BB Murine Recombinant Protein Guide

  2026-08-18

  PDGF-BB, including murine recombinant PDGF-BB, is a defined mitogenic growth factor for receptor signaling and cell proliferation assays. Product specifications support controlled use in BALB/c 3T3 assays, while recent pulmonary hypertension research places smooth muscle cell proliferation within a lactate–ALDOB–DRP1 mechanism.

• Glabridin–Gold(I) Complex and Antitumor Immunity

  2026-08-18

  The reference study develops complex 6d by integrating an N-heterocyclic carbene gold(I) center with glabridin to target thioredoxin reductase and MAPK signaling. In liver cancer models, this design reportedly increased dendritic-cell maturation, reduced immunosuppressive immune populations, lowered tumor-cell PD-L1, and enhanced T-cell granzyme B production, supporting further evaluation of redox-directed immunomodulation.

• Catalpol in Alzheimer’s Disease: Mechanisms and Evidence

  2026-08-17

  This review synthesizes preclinical evidence that catalpol, an iridoid glycoside from Rehmannia glutinosa, may protect against Alzheimer’s disease through antioxidant, anti-inflammatory, antiapoptotic, and broader neuroprotective actions. Its main practical contribution is a multitarget framework for designing experiments that connect cognitive outcomes with cellular, molecular, and tissue-level mechanisms.

• EZ Cap™ Firefly Luciferase mRNA for LNP QC

  2026-08-16

  EZ Cap™ Firefly Luciferase mRNA can function as more than a reporter: it provides a sensitive functional readout for mRNA delivery, translation, and formulation effects. This article connects Cap1-enabled expression with citrate-buffer decisions in LNP development and assay design.

• Ceramides Drive RGNNV Infection Through Autophagy

  2026-08-15

  A 2026 Journal of Virology study uses global lipidomics and functional perturbation to show that red-spotted grouper nervous necrosis virus redirects ceramide metabolism to support replication. Ceramide synthesis, particularly C16-ceramide, promoted infection partly by enhancing virus-associated autophagy, identifying sphingolipid flux as a potential antiviral research target.

• Bestatin (Ubenimex): Mechanism & Research Use

  2026-08-15

  Bestatin, also called Ubenimex, is a research inhibitor of aminopeptidase B, leucine aminopeptidase, and selected aminopeptidase N-related activities. Its reported biochemical potency, cell-assay use, storage requirements, and in vivo research boundaries support controlled applications in aminopeptidase activity measurement, apoptosis assay design, multidrug resistance research, and cancer research.

• Biotin (Vitamin B7) for STING Assay Design

  2026-08-14

  Biotin and Vitamin B7 are more than metabolic cofactors: they can support modular assay architectures for studying DNA-sensing proteins. This article connects biotin chemistry with shrimp STING research while distinguishing validated findings from proposed experimental workflows.

• Okadaic acid (A4540): PP1/PP2A Workflow Guide

  2026-08-14

  Okadaic acid (SKU A4540) provides a concentration-dependent way to inhibit PP2A predominantly at low nanomolar levels and PP1 at higher nanomolar levels in biochemical and cell-based studies. It is useful for phosphorylation signaling and apoptosis workflows, but it should not be treated as a universal phosphatase inhibitor or as evidence of pathway-specific causality without appropriate controls.

• BACE Inhibition and Synaptic Transmission in Neurons

  2026-08-13

  Satir and colleagues tested whether partial β-secretase inhibition could lower amyloid-β production without disrupting neuronal communication. Using primary cortical rat neurons, optical electrophysiology, and secreted Aβ measurements, they found that reductions below 50% preserved synaptic transmission, whereas stronger inhibition impaired it.

• DGLA–ACSL4 Ferroptosis in AML Cells

  2026-08-13

  A study in Translational Oncology identifies dihomo-γ-linolenic acid (DGLA) as a ferroptosis-inducing lipid vulnerability in acute myeloid leukemia (AML). By combining targeted metabolomics, ACSL4 loss-of-function experiments, and in vivo dietary intervention, the work connects fatty-acid remodeling with ferroptosis sensitivity and suggests a preclinical strategy for AML research.

• Carbapenemase Gene Transfer in CREC Across Guangdong

  2026-08-12

  Chen et al. characterize carbapenemase-encoding genes in 54 carbapenem-resistant Enterobacter cloacae isolates from eight teaching hospitals in Guangdong, combining gene localization, antimicrobial susceptibility, conjugation, mobile-element analysis, and ERIC-PCR typing. The study identifies plasmid-associated blaNDM-1, extensive multidrug resistance, and efficient in vitro gene transfer as major features relevant to infection-control surveillance.

• CCT007093: Practical PPM1D Inhibitor Workflows

  2026-08-12

  CCT007093 is a research-ready PPM1D inhibitor for connecting phosphatase activity with P38 MAPK signaling, cell viability, and inflammatory cell death. Its value is strongest in orthogonal workflows that combine biochemical inhibition, early phospho-P38 measurements, viability assays, and pathway-rescue controls.

446 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page